Dr Aung Pyae Phyo
Aung Pyae Phyo
Aung Pyae Phyo is a a Burmese (Myanmar) Post-doctoral Researcher at MORU's Shoklo Malaria Research Unit (SMRU) in Mae Sot, Thailand. After finishing medical training in 2001 in Yangon, Aung joined SMRU as a research assistant (2005-2008), research clinician (2009-2013) and DPhil student (2013-2017).
After receiving his DPhil in Clinical Medicine at Oxford University in 2017, Aung moved to MORU's Myanmar Oxford Clinical Research Unit (MOCRU) in Yangon, Myanmar and worked as a senior clinician scientist until 2021. In 2019 he received the post-doctoral International Training fellowship from the Wellcome Trust to assess tthe immune decay after malaria elimination and the risk of malaria resurgence, and a seed grant from Australian Centre of Research Excellence in Malaria Elimination (ACREME) for the project: Field evaluation of a point-of-contact device for P. falciparum malaria sero-surveillance.
Aung's current research focus is malaria elimination, malaria immunity and anti-microbial resistance.
Artemisinin resistance in the malaria parasite, Plasmodium falciparum, originates from its initial transcriptional response.
Zhu L. et al, (2022), Communications biology, 5
Defining the burden of febrile illness in rural South and Southeast Asia: an open letter to announce the launch of the Rural Febrile Illness project
Chandna A. et al, (2022), Wellcome Open Research, 6, 64 - 64
Clinical impact of vivax malaria: A collection review
Phyo AP. et al, (2022), PLOS Medicine, 19, e1003890 - e1003890
A randomized controlled trial of dihydroartemisinin-piperaquine, artesunate-mefloquine and extended artemether-lumefantrine treatments for malaria in pregnancy on the Thailand-Myanmar border
Saito M. et al, (2021), BMC Medicine, 19
Triple artemisinin-based combination therapies for malaria: proceed with caution - Authors' reply.
van der Pluijm RW. et al, (2021), Lancet (London, England), 396, 1976 - 1977